Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure

Huiying Gu, Gregory Robison, Lan Hong, Raul Barrea, Xing Wei, Martin Farlow, Yulia N. Pushkar, Yansheng Du, Wei Zheng

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Previous studies in humans and animals have suggested a possible association between lead (Pb) exposure and the etiology of Alzheimer's disease (AD). Animals acutely exposed to Pb display an over-expressed amyloid precursor protein (APP) and the ensuing accumulation of beta-amyloid (Aβ) in brain extracellular spaces. This study was designed to examine whether in vivo Pb exposure increased brain concentrations of Aβ, resulting in amyloid plaque deposition in brain tissues. Human Tg-SWDI APP transgenic mice, which genetically over-express amyloid plaques at age of 2-3 months, received oral gavages of 50. mg/kg Pb acetate once daily for 6 weeks; a control group of the same mouse strain received the same molar concentration of Na acetate. ELISA results revealed a significant increase of Aβ in the CSF, brain cortex and hippocampus. Immunohistochemistry displayed a detectable increase of amyloid plaques in brains of Pb-exposed animals. Neurobehavioral test using Morris water maze showed an impaired spatial learning ability in Pb-treated mice, but not in C57BL/6 wild type mice with the same age. In vitro studies further uncovered that Pb facilitated Aβ fibril formation. Moreover, the synchrotron X-ray fluorescent studies demonstrated a high level of Pb present in amyloid plaques in mice exposed to Pb in vivo. Taken together, these data indicate that Pb exposure with ensuing elevated Aβ level in mouse brains appears to be associated with the amyloid plaques formation. Pb apparently facilitates Aβ fibril formation and participates in deposition of amyloid plaques.

Original languageEnglish
Pages (from-to)211-219
Number of pages9
JournalToxicology Letters
Volume213
Issue number2
DOIs
StatePublished - Sep 3 2012

Fingerprint

Amyloid Plaques
Amyloid
Transgenic Mice
Brain
Amyloid beta-Protein Precursor
Animals
Acetates
Synchrotrons
Extracellular Space
Lead
Hippocampus
Alzheimer Disease
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
X-Rays
Control Groups
Tissue
Water
X rays

Keywords

  • Amyloid plaques
  • Beta-amyloid or Aβ
  • Fibril formation
  • Hippocampus
  • Lead (Pb)
  • Tg-SWDI mouse
  • X-ray fluorescence or XRF

ASJC Scopus subject areas

  • Toxicology

Cite this

Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure. / Gu, Huiying; Robison, Gregory; Hong, Lan; Barrea, Raul; Wei, Xing; Farlow, Martin; Pushkar, Yulia N.; Du, Yansheng; Zheng, Wei.

In: Toxicology Letters, Vol. 213, No. 2, 03.09.2012, p. 211-219.

Research output: Contribution to journalArticle

Gu, Huiying ; Robison, Gregory ; Hong, Lan ; Barrea, Raul ; Wei, Xing ; Farlow, Martin ; Pushkar, Yulia N. ; Du, Yansheng ; Zheng, Wei. / Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure. In: Toxicology Letters. 2012 ; Vol. 213, No. 2. pp. 211-219.
@article{494dc90397a04f5f85485e87aa875558,
title = "Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure",
abstract = "Previous studies in humans and animals have suggested a possible association between lead (Pb) exposure and the etiology of Alzheimer's disease (AD). Animals acutely exposed to Pb display an over-expressed amyloid precursor protein (APP) and the ensuing accumulation of beta-amyloid (Aβ) in brain extracellular spaces. This study was designed to examine whether in vivo Pb exposure increased brain concentrations of Aβ, resulting in amyloid plaque deposition in brain tissues. Human Tg-SWDI APP transgenic mice, which genetically over-express amyloid plaques at age of 2-3 months, received oral gavages of 50. mg/kg Pb acetate once daily for 6 weeks; a control group of the same mouse strain received the same molar concentration of Na acetate. ELISA results revealed a significant increase of Aβ in the CSF, brain cortex and hippocampus. Immunohistochemistry displayed a detectable increase of amyloid plaques in brains of Pb-exposed animals. Neurobehavioral test using Morris water maze showed an impaired spatial learning ability in Pb-treated mice, but not in C57BL/6 wild type mice with the same age. In vitro studies further uncovered that Pb facilitated Aβ fibril formation. Moreover, the synchrotron X-ray fluorescent studies demonstrated a high level of Pb present in amyloid plaques in mice exposed to Pb in vivo. Taken together, these data indicate that Pb exposure with ensuing elevated Aβ level in mouse brains appears to be associated with the amyloid plaques formation. Pb apparently facilitates Aβ fibril formation and participates in deposition of amyloid plaques.",
keywords = "Amyloid plaques, Beta-amyloid or Aβ, Fibril formation, Hippocampus, Lead (Pb), Tg-SWDI mouse, X-ray fluorescence or XRF",
author = "Huiying Gu and Gregory Robison and Lan Hong and Raul Barrea and Xing Wei and Martin Farlow and Pushkar, {Yulia N.} and Yansheng Du and Wei Zheng",
year = "2012",
month = "9",
day = "3",
doi = "10.1016/j.toxlet.2012.07.002",
language = "English",
volume = "213",
pages = "211--219",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure

AU - Gu, Huiying

AU - Robison, Gregory

AU - Hong, Lan

AU - Barrea, Raul

AU - Wei, Xing

AU - Farlow, Martin

AU - Pushkar, Yulia N.

AU - Du, Yansheng

AU - Zheng, Wei

PY - 2012/9/3

Y1 - 2012/9/3

N2 - Previous studies in humans and animals have suggested a possible association between lead (Pb) exposure and the etiology of Alzheimer's disease (AD). Animals acutely exposed to Pb display an over-expressed amyloid precursor protein (APP) and the ensuing accumulation of beta-amyloid (Aβ) in brain extracellular spaces. This study was designed to examine whether in vivo Pb exposure increased brain concentrations of Aβ, resulting in amyloid plaque deposition in brain tissues. Human Tg-SWDI APP transgenic mice, which genetically over-express amyloid plaques at age of 2-3 months, received oral gavages of 50. mg/kg Pb acetate once daily for 6 weeks; a control group of the same mouse strain received the same molar concentration of Na acetate. ELISA results revealed a significant increase of Aβ in the CSF, brain cortex and hippocampus. Immunohistochemistry displayed a detectable increase of amyloid plaques in brains of Pb-exposed animals. Neurobehavioral test using Morris water maze showed an impaired spatial learning ability in Pb-treated mice, but not in C57BL/6 wild type mice with the same age. In vitro studies further uncovered that Pb facilitated Aβ fibril formation. Moreover, the synchrotron X-ray fluorescent studies demonstrated a high level of Pb present in amyloid plaques in mice exposed to Pb in vivo. Taken together, these data indicate that Pb exposure with ensuing elevated Aβ level in mouse brains appears to be associated with the amyloid plaques formation. Pb apparently facilitates Aβ fibril formation and participates in deposition of amyloid plaques.

AB - Previous studies in humans and animals have suggested a possible association between lead (Pb) exposure and the etiology of Alzheimer's disease (AD). Animals acutely exposed to Pb display an over-expressed amyloid precursor protein (APP) and the ensuing accumulation of beta-amyloid (Aβ) in brain extracellular spaces. This study was designed to examine whether in vivo Pb exposure increased brain concentrations of Aβ, resulting in amyloid plaque deposition in brain tissues. Human Tg-SWDI APP transgenic mice, which genetically over-express amyloid plaques at age of 2-3 months, received oral gavages of 50. mg/kg Pb acetate once daily for 6 weeks; a control group of the same mouse strain received the same molar concentration of Na acetate. ELISA results revealed a significant increase of Aβ in the CSF, brain cortex and hippocampus. Immunohistochemistry displayed a detectable increase of amyloid plaques in brains of Pb-exposed animals. Neurobehavioral test using Morris water maze showed an impaired spatial learning ability in Pb-treated mice, but not in C57BL/6 wild type mice with the same age. In vitro studies further uncovered that Pb facilitated Aβ fibril formation. Moreover, the synchrotron X-ray fluorescent studies demonstrated a high level of Pb present in amyloid plaques in mice exposed to Pb in vivo. Taken together, these data indicate that Pb exposure with ensuing elevated Aβ level in mouse brains appears to be associated with the amyloid plaques formation. Pb apparently facilitates Aβ fibril formation and participates in deposition of amyloid plaques.

KW - Amyloid plaques

KW - Beta-amyloid or Aβ

KW - Fibril formation

KW - Hippocampus

KW - Lead (Pb)

KW - Tg-SWDI mouse

KW - X-ray fluorescence or XRF

UR - http://www.scopus.com/inward/record.url?scp=84864423838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864423838&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2012.07.002

DO - 10.1016/j.toxlet.2012.07.002

M3 - Article

C2 - 22796588

AN - SCOPUS:84864423838

VL - 213

SP - 211

EP - 219

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 2

ER -